Management to host conference call today at 5pm CEST / 11am ET today - details provided below

Gosselies, Belgium, 8 September 2021, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces a business update and its financial results for the six-month period ended 30 June 2021, prepared in accordance with IFRS as adopted by the European Union, and the outlook for the remainder of the year.

'At the end of the first half of 2021, Bone Therapeutics has now developed a clear route forward for the company, with a full focus on expanding its allogeneic differentiated MSC based cell therapy platform, beyond our current orthopedic focus for ALLOB, into other therapeutic indications. This expansion has been built on the evidence of our clinical progress on orthopedics, and demonstrated a foundation to broaden our focus to wider indications,' said Miguel Forte, MD, PhD, Chief Executive Officer of Bone Therapeutics. 'Now we have concluded the current stage of clinical progress of JTA, this allows all financial, managerial and scientific resources to be focused on delivering therapeutic benefit from our core MSC technology. These resources include our appointments throughout 2021, including the appointments of stem cell therapy industry veteran, Anthony Ting, PhD, as Chief Scientific Officer and Dr. Anne Leselbaum as Chief Medical Officer. We look forward to the development of MSC based therapies to bring options to a wider group of patients.'


Operational and Corporate Highlights


Conference call
Miguel Forte, MD, PhD, Chief Executive Officer, and Jean-Luc Vandebroek, Chief Financial Officer, will host a conference call today at 5pm CEST / 11am ET. To participate in the conference call, please select your phone number below and use the conference ID 880 4181 7984#. Belgium: +32 2 290 9360 France: +33 1 7095 0103 United Kingdom: +44 208 080 6592 United States: +1 646 876 9923 The conference call will also be webcast and can be attended via the following link:
https://us06web.zoom.us/j/88041817984 The presentation will be made available on the Investors section - Presentations of the Bone Therapeutics website shortly prior the call.

Attachments

  • Original document
  • Permalink

Disclaimer

Bone Therapeutics SA published this content on 08 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 September 2021 05:11:08 UTC.